Ligand validation:3T2P

IPT: 1-methylethyl 1-thio-beta-D-galactopyranoside

IPT is a Ligand Of Interest in 3T2P designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3T2P_IPT_D_2001	69%	63%	0.144	0.959	0.58	0.84	-	1	0	0	100%	0.96
3T2P_IPT_A_2001	61%	63%	0.154	0.943	0.53	0.87	-	1	0	0	100%	0.95
3T2P_IPT_B_2001	61%	65%	0.159	0.948	0.53	0.81	-	-	0	0	100%	1
3T2P_IPT_C_2001	55%	62%	0.176	0.944	0.55	0.9	-	1	0	0	100%	1
1PX4_IPT_C_2001	95%	49%	0.072	0.975	0.61	1.35	-	3	0	0	100%	1
1JYX_IPT_D_2001	94%	38%	0.074	0.974	0.43	1.97	-	5	0	0	100%	0.96
3DYO_IPT_C_2001	90%	47%	0.085	0.969	0.68	1.36	-	3	0	0	100%	1
3T0B_IPT_B_2001	89%	41%	0.087	0.965	0.52	1.74	-	2	0	0	100%	1
3T08_IPT_B_2001	88%	60%	0.086	0.962	0.57	0.94	-	-	0	0	100%	1
2P9H_IPT_A_998	90%	30%	0.098	0.981	1.39	1.39	1	2	0	0	100%	1
4OUE_IPT_A_502	88%	36%	0.107	0.984	1.4	1.14	1	1	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.